Ameriprise’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8M Buy
1,710,971
+47,635
+3% +$385K ﹤0.01% 1583
2025
Q1
$13.9M Buy
1,663,336
+124,089
+8% +$1.04M ﹤0.01% 1544
2024
Q4
$12.2M Sell
1,539,247
-49,121
-3% -$389K ﹤0.01% 1652
2024
Q3
$13.2M Buy
1,588,368
+1,577,644
+14,711% +$13.1M ﹤0.01% 1582
2024
Q2
$68.1K Sell
10,724
-385
-3% -$2.45K ﹤0.01% 3804
2024
Q1
$67.3K Sell
11,109
-70,931
-86% -$430K ﹤0.01% 3803
2023
Q4
$498K Buy
82,040
+12,843
+19% +$78K ﹤0.01% 3448
2023
Q3
$292K Buy
69,197
+52,677
+319% +$222K ﹤0.01% 3589
2023
Q2
$51.2K Sell
16,520
-101,686
-86% -$315K ﹤0.01% 3859
2023
Q1
$164K Buy
118,206
+31,901
+37% +$44.3K ﹤0.01% 3765
2022
Q4
$172K Buy
86,305
+26,851
+45% +$53.5K ﹤0.01% 3732
2022
Q3
$120K Buy
59,454
+32,802
+123% +$66.2K ﹤0.01% 3792
2022
Q2
$85K Buy
26,652
+9,436
+55% +$30.1K ﹤0.01% 3801
2022
Q1
$72K Buy
17,216
+116
+0.7% +$485 ﹤0.01% 3865
2021
Q4
$82K Sell
17,100
-850
-5% -$4.08K ﹤0.01% 3879
2021
Q3
$96K Buy
17,950
+100
+0.6% +$535 ﹤0.01% 3780
2021
Q2
$91K Buy
+17,850
New +$91K ﹤0.01% 3827
2020
Q4
Sell
-76,135
Closed -$296K 3750
2020
Q3
$296K Buy
76,135
+27,825
+58% +$108K ﹤0.01% 3424
2020
Q2
$230K Sell
48,310
-70,030
-59% -$333K ﹤0.01% 3443
2020
Q1
$413K Buy
+118,340
New +$413K ﹤0.01% 3194
2019
Q3
Sell
-987,608
Closed -$7.08M 3699
2019
Q2
$7.08M Sell
987,608
-838,677
-46% -$6.01M ﹤0.01% 1983
2019
Q1
$25.9M Sell
1,826,285
-31,384
-2% -$445K 0.01% 972
2018
Q4
$25.1M Sell
1,857,669
-81,430
-4% -$1.1M 0.01% 927
2018
Q3
$43M Sell
1,939,099
-1,106,394
-36% -$24.6M 0.02% 825
2018
Q2
$50M Buy
+3,045,493
New +$50M 0.02% 674